HIF1A and neoplasm: The important role of the hypoxic tumor microenvironment in driving tumor progression and the development of therapeutic resistance has recently been recognized and has a key role in the tumor stroma HIF-1α, leading to an increasing clinical research focus on discovering new therapies that inhibit this protein or its targets41.